ARAshvita Ramesh

Ashvita Ramesh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ashvita Ramesh has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • SUBCLINICAL CHANGES IN LEFT AND RIGHT VENTRICULAR STRAIN AS DETERMINED BY SPECKLE-TRACKING ECHOCARDIOGRAPHIC ANALYSIS AFTER TRANSCATHETER OR SURGICAL AORTIC-VALVE REPLACEMENT

    by Olga N. Kislitsina, Bonnie Kane, Adin-Cristian Andrei, James Thomas, Jane Kruse, Andrei Churyla, Ashvita Ramesh, Ranya Sweis, James Flaherty, Charles Davidson, et al.


  • Open Access

    A cell-free biosynthesis platform for modular construction of protein glycosylation pathways

    by Weston Kightlinger, Katherine E. Duncker, Ashvita Ramesh, Ariel H. Thames, Aravind Natarajan, Jessica C. Stark, Allen Yang, Liang Lin, Milan Mrksich, Matthew P. DeLisa, et al.

    Glycosylation plays important roles in cellular function and endows protein therapeutics with beneficial properties. However, constructing biosynthetic pathways to study and engineer precise glycan structures on proteins remains a bottleneck. Here, we report a modular, versatile cell-free platform for glycosylation pathway assembly by rapid in vitro mixing and expression (GlycoPRIME). In GlycoPRIME, glycosylation pathways are assembled by mixing-and-matching cell-free synthesized glycosyltransferases that can elaborate a glucose primer installed onto protein targets by an N-glycosyltransferase. We demonstrate GlycoPRIME by constructing 37 putative protein glycosylation pathways, creating 23 unique glycan motifs, 18 of which have not yet been synthesized on proteins. We use selected pathways to synthesize a protein vaccine candidate with an α-galactose adjuvant motif in a one-pot cell-free system and human antibody constant regions with minimal sialic acid motifs in glycoengineered Escherichia coli. We anticipate that these methods and pathways will facilitate glycoscience and make possible new glycoengineering applications.


  • Open Access

    A cell-free biosynthesis platform for modular construction of protein glycosylation pathways

    by Weston Kightlinger, Katherine E. Duncker, Ashvita Ramesh, Ariel H. Thames, Aravind Natarajan, Allen Yang, Jessica C. Stark, Liang Lin, Milan Mrksich, Matthew P. DeLisa, et al.

    Glycosylation plays important roles in cellular function and endows protein therapeutics with beneficial properties. However, constructing biosynthetic pathways to study and engineer protein glycosylation remains a bottleneck. To address this limitation, we describe a modular, versatile cell-free platform for glyco sylation p athway assembly by rapid in vitro m ixing and e xpression (GlycoPRIME). In GlycoPRIME, crude cell lysates are enriched with glycosyltransferases by cell-free protein synthesis and then glycosylation pathways are assembled in a mix-and-match fashion to elaborate a single glucose priming handle installed by an N -linked glycosyltransferase. We demonstrate GlycoPRIME by constructing 37 putative protein glycosylation pathways, creating 23 unique glycan motifs. We then use selected pathways to design a one-pot cell-free system to synthesize a vaccine protein with an α-galactose motif and engineered Escherichia coli strains to produce human antibody constant regions with minimal sialic acid motifs. We anticipate that our work will facilitate glycoscience and make possible new glycoengineering applications.